Literature DB >> 23220010

Ubiquitin C-terminal Hydrolase 37, a novel predictor for hepatocellular carcinoma recurrence, promotes cell migration and invasion via interacting and deubiquitinating PRP19.

Ying Fang1, Da Fu, Wenqing Tang, Yu Cai, Duan Ma, Huijun Wang, Ruyi Xue, Taotao Liu, Xiaowu Huang, Ling Dong, Hao Wu, Xizhong Shen.   

Abstract

Ubiquitin C-terminal hydrolase 37 (UCH37) plays a crucial role in numerous biological processes and is also involved in oncogenesis. In this study, clinicopathologic data showed that UCH37 was over-expressed in hepatocellular carcinoma (HCC) cancerous tissues and was a significant predictor for time to recurrence (TTR). In vitro, we discovered that UCH37 could promote cell migration and invasion. Subsequently, we utilized Isobaric Tags for Relative and Absolute Quantitation (iTRAQ) to identify differentially expressed proteins in UCH37 over-expressing cells compared with the control cells, and found that PRP19, an essential RNA splicing factor, was up-regulated. The relationship between UCH37, PRP19 and the capability of cell migration and invasion was further confirmed. Collectively, this study demonstrated that UCH37 could promote cell migration and invasion in HCC cell lines through interacting and deubiquitinating PRP19, and suggested that UCH37 could be a novel predictor for HCC recurrence after curative resection.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23220010     DOI: 10.1016/j.bbamcr.2012.11.020

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  32 in total

1.  Regulation of E2 promoter binding factor 1 (E2F1) transcriptional activity through a deubiquitinating enzyme, UCH37.

Authors:  Christina S Mahanic; Varija Budhavarapu; Joshua D Graves; Gang Li; Weei-Chin Lin
Journal:  J Biol Chem       Date:  2015-09-22       Impact factor: 5.157

2.  Phosphorylation of Tyr-950 in the proteasome scaffolding protein RPN2 modulates its interaction with the ubiquitin receptor RPN13.

Authors:  Casey W Hemmis; Stephanie C Heard; Christopher P Hill
Journal:  J Biol Chem       Date:  2019-05-07       Impact factor: 5.157

3.  High expression of UCH37 is significantly associated with poor prognosis in human epithelial ovarian cancer.

Authors:  Lin Wang; Yan-Jie Chen; Kai Xu; Ya-Yun Wang; Xi-Zhong Shen; Rui-Qin Tu
Journal:  Tumour Biol       Date:  2014-08-15

4.  MicroRNA-33a downregulation is associated with tumorigenesis and poor prognosis in patients with hepatocellular carcinoma.

Authors:  Ru-Ting Xie; Xian-Ling Cong; Xiao-Ming Zhong; Ping Luo; Hui-Qiong Yang; Gai-Xia Lu; Pei Luo; Zheng-Yan Chang; Ran Sun; Ting-Miao Wu; Zhong-Wei Lv; Da Fu; Yu-Shui Ma
Journal:  Oncol Lett       Date:  2018-01-29       Impact factor: 2.967

5.  Desmoglein-2 is overexpressed in non-small cell lung cancer tissues and its knockdown suppresses NSCLC growth by regulation of p27 and CDK2.

Authors:  Feng Cai; Qingqing Zhu; Yingying Miao; Simei Shen; Xin Su; Yi Shi
Journal:  J Cancer Res Clin Oncol       Date:  2016-09-14       Impact factor: 4.553

6.  Proteasome-Bound UCH37/UCHL5 Debranches Ubiquitin Chains to Promote Degradation.

Authors:  Kirandeep K Deol; Sean O Crowe; Jiale Du; Heather A Bisbee; Robert G Guenette; Eric R Strieter
Journal:  Mol Cell       Date:  2020-11-05       Impact factor: 17.970

7.  NEDD4 promotes cell growth and motility in hepatocellular carcinoma.

Authors:  Hailun Zheng; Xiquan Ke; Dapeng Li; Qiangwu Wang; Jianchao Wang; Xiaoyang Liu; Min Deng; Xiaojing Deng; Yongju Xue; Yu Zhu; Qizhi Wang
Journal:  Cell Cycle       Date:  2018-04-10       Impact factor: 4.534

8.  A fluorescence polarization-based competition assay for measuring interactions between unlabeled ubiquitin chains and UCH37•RPN13.

Authors:  Jiale Du; Eric R Strieter
Journal:  Anal Biochem       Date:  2018-04-23       Impact factor: 3.365

Review 9.  Meddling with Fate: The Proteasomal Deubiquitinating Enzymes.

Authors:  Stefanie A H de Poot; Geng Tian; Daniel Finley
Journal:  J Mol Biol       Date:  2017-10-05       Impact factor: 5.469

Review 10.  Repurposing old drugs as new inhibitors of the ubiquitin-proteasome pathway for cancer treatment.

Authors:  Huanjie Yang; Xin Chen; Kai Li; Hassan Cheaito; Qianqian Yang; Guojun Wu; Jinbao Liu; Q Ping Dou
Journal:  Semin Cancer Biol       Date:  2019-12-26       Impact factor: 15.707

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.